JOINT FILING AGREEMENT
Exhibit
3
In
accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
as
amended, each of the undersigned Reporting Persons hereby agrees to the joint
filing, along with all other such Reporting Persons, on behalf of each of
them
of a statement on Schedule 13D (including amendments thereto) with respect
to
shares of Common Stock, $0.01 par value per share, of ENDO Pharmaceuticals
Holdings Inc., and that this Agreement be included as an Exhibit to such
joint
filing. This Agreement may be executed in any number of counterparts,
all of which taken together shall constitute one and the same
instrument.
IN
WITNESS WHEREOF, each of the undersigned hereby executes this Agreement as
of
this 27th day of July, 2007.
D.
E.
SHAW SYNOPTIC PORTFOLIOS 2, L.L.C.
|
By: X.
X. XXXX & CO., L.L.C., as Managing
Member
|
|
By:
/s/Xxxx
Dinning________________________
|
|
Name:
Xxxx Xxxxxxx
|
|
Title:
Managing Director
|
D.
E.
SHAW VALENCE PORTFOLIOS, L.L.C.
|
By: X.
X. XXXX & CO., L.P., as Managing
Member
|
|
By:
/s/Xxxx
Dinning_________________________
|
|
Name:
Xxxx Xxxxxxx
|
|
Title:
Managing Director
|
D.
E.
SHAW COMPOSITE PORTFOLIOS, L.L.C.
|
By: X.
X. XXXX & CO., L.L.C., as Managing
Member
|
|
By:/s/Xxxx
Dinning__________________________
|
|
Name:
Xxxx Xxxxxxx
|
|
Title:
Managing Director
|
D.
E.
SHAW INVESTMENT MANAGEMENT, L.L.C.
|
By: X.
X. XXXX & CO., L.P., as Managing
Member
|
|
By:
/s/Xxxx
Dinning_________________________
|
|
Name:
Xxxx Xxxxxxx
|
|
Title:
Managing Director
|
X.
X.
XXXX & Co., L.L.C.
|
By:
/s/Xxxx
Dinning________________________
|
|
Name:
Xxxx Xxxxxxx
|
|
Title:
Managing Director
|
X.
X.
XXXX & Co., L.P.
|
By: /s/Xxxx
Dinning_______________________
|
|
Name:
Xxxx Xxxxxxx
|
|
Title:
Managing Director
|
XXXXX
X.
XXXX
|
By:/s/Xxxx
Dinning___________________________
|
|
Name:
Xxxx Xxxxxxx
|
|
Title:
Attorney-in-Fact for Xxxxx X.
Xxxx
|